ARK GENOMIC REVOLUTION ETF | ARKG

Medium RiskARKGMorning Star4 / 5
ARK GENOMIC REVOLUTION ETF
Issued by:ARK Investment Management LLC
Unit Price (NAV) : $
Minimum investment: 3 units
Share
Compare
Share
Compare
ARK GENOMIC REVOLUTION ETF | ARKG

ARK GENOMIC REVOLUTION ETF | ARKG

About ARKG ETF

Overview:
ARK Genomic Revolution ETF invests in companies which are focused on and are expected to substantially benefit from extending and enhancing the quality of human and other life by incorporating technological and scientific developments and advancements in genomics into their business.
The companies held in ARKG may develop, produce or enable:

  • CRISPR
  • Targeted Therapeutics
  • Bioinformatics
  • Molecular Diagnostics
  • Stem Cells
  • Agricultural Biology
ARKG will be concentrated in issuers in any industry or group of industries in the health care sector, including issuers having their principal business activities in the biotechnology industry.
ARKG is an actively managed ETF that seeks long-term growth of capital by investing under normal circumstances primarily (at least 80% of its assets) in domestic and U.S. exchange traded foreign equity securities of companies across multiple sectors, including health care, information technology, materials, energy and consumer discretionary, that are relevant to the Fund?s investment theme of the genomics revolution.

Recommended for:
Growth

ARKG ChartsLifetime22.59%
ARKG Performance1Y3Y5Y
This ETF28.14%36.77%17.92%

Projected Returns

Investment ofper month
gives returns of :
at 17.92% / annum
$in 5 years
amount
for a time period of
time1Y3Y5Y
Returns % (CAGR)based on historic returns of 17.92% per annum
$
$
$+ 17.92%

Asset Class

Asset type breakdown
Stock US82.66%
Stock non-US17.09%
Cash0.25%

ARKG Holdings - Top 10

NameiWeightage (%)
Arcturus Therapeutics Holdings, Inc.8.70%
CRISPR Therapeutics AG8.63%
Illumina, Inc.8.44%
Invitae Corp.8.05%
Compugen Ltd.5.92%
Intellia Therapeutics, Inc.4.81%
Iovance Biotherapeutics Inc4.70%
Editas Medicine, Inc.3.57%
Guardant Health, Inc.3.57%
Twist Bioscience Corp.3.54%

ARKG Sectors/Industry Breakdown

Sectori% of market value
Healthcare98.23%
Technology1.62%
Consumer Defensive0.15%

ARKG Countries

Country% of market value
North America82.87%
Europe Developed11.01%
Africa/Middle East6.13%

ARKG Summary Data

Fund Size(AUM) $i
Avg. mkt. cap (MM) $i
Morningstar Ratings 4i
Symbol ARKG
Exchange ARCX
Asset class ARKG

ARKG Portfolio Data & Volatility Analysis

Expense ratio 0.75i
Beta 1.52i
P/E ratio 39.62795i
Standard Deviation 35.72i
ARK GENOMIC REVOLUTION ETF | ARKG